Juice cleanses are a popular way to kickstart a health journey, but these diets may do more harm than good in as little as three days.

A study published recently in the journal Nutrients found that consuming vegetable and fruit juice-only diets for three days triggered detrimental gut and oral bacteria changes linked to inflam...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake.

The research found that, compared to placebo, weekly injections of semaglutide (also marketed for weight loss as Wegovy) helped reduce cravings in people with alcohol use disorders. The drug also seemed to reduce t...

“Yo-yo” dieting -- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns.

Diabetics with greater weight fluctuations experienced a 40% decline in their kidneys’ ability to filter toxins from th...

Weight-loss surgery can protect the liver health of patients with obesity and fatty liver disease, a new study reports.

Patients had a 72% lower risk of developing serious complications of liver disease after undergoing weight-loss surgery, researchers reported in Jan. 27 in the journal Nature Medicine.

They a...

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia. 

But these drugs also come with risks that shouldn't be overlooked, researchers warn ...

Black people with obesity are less likely to get weight-loss surgery than others.

Black people are just as likely to discuss the procedure with their doctor -- nearly 10%, compared with 9% of patients of other races, researchers said.

But only about 8% of those Black patients go on and actually get the surgery, compared with nearly 13% of other patients, researchers report in a stud...

The way obesity is diagnosed needs to become more sophisticated, an international commission has concluded.

Using body-mass index (BMI) to tell who is overweight or obese is not reliable, and can result in misdiagnosis, the Commission on Clinical Obesity says in a new paper published today in The Lancet Diabetes & En...